Market Research Blog – Page 11784 – New Product Development

IoT in Healthcare Market is projected to reaching US$ 952.3 Billion by 2032

[297 Pages Report] The global IoT in healthcare market is projected to reach US$ 181.4 Billion in 2022, anticipated to grow at a CAGR of 18.0%, reaching US$ 952.3 Billion by 2032. The market is slated to document a Y-o-Y growth rate of 20.7% from 2021-2022, increasing from the previously registered value of US$ 150.3 Billion.

By enabling real-time patient data access and remote patient monitoring, the Internet of Things (IoT) has the potential to disrupt traditional paper-based healthcare therapy. With the emergence of this digital healthcare technology, the impending need for enhanced diagnostics and targeted therapeutic options was met.

Furthermore, it not only enables physicians to remotely monitor patients, but it also functions as a fitness and wellness tracker for athletes and a dose reminder for patients. The successful implementation of IoT in remote monitoring of diabetic and asthma patients, along with the growing usage of fitness and wellness devices, has resulted in a considerable demand for the IoT healthcare business.

Download FREE Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-14639

Key Takeaways from the Market Study
•IoT in healthcare experienced a growth rate worth 18.8% between 2015 and 2021

•Portable diagnostic devices in the IoT in Healthcare segment to expand at a CAGR of 10.1% during the forecast period

•In the U.S., the market is predicted to reach US$ 208.1 Billion while growing at a CAGR of 18.9% during the forecast period

•China’s market is expected to reach a market value of US$ 92.8 Billion with a CAGR of 19.5% during the forecast period

“Big data analytics is an area of IoT that is quickly expanding. The most recent breakthroughs in machine learning, logical procedures, computational intelligence, and data mining are required for big data analytics”, says an FMI analyst.

Ask for Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-14639

Competitive Landscape

Key players that have been profiled in the report are Apple Inc., Cisco Systems Inc., GE Healthcare Ltd., Google (Alphabet), International Business Machines
Corporation, Medtronic PLC, Microsoft Corporation, Proteus Digital Health, Koninklijke Philips N.V., QUALCOMM Incorporated, and Abbot Laboratories are among companies that offer products and technologies that will allow customers to take advantage of new technologies.

•In April 2019, Royal Philips and Spencer Health Solutions expanded their relationship to provide chronically sick patients in selected European Union (EU) nations with in-home medication adherence and the Philips telehealth platform.

•Medtronic worked with IBM Watson in January 2019 to provide IQcast, a new feature of its current product Sugar.IQ, for iOS mobile devices in the United States. The software would provide patients with a hypoglycemic episode to monitor their low glucose level by anticipating the occurrence 1 to 4 hours in advance.

About FMI:

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006,
Jumeirah Bay 2,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers,
Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs

Medical Physics Market Key Players : Gilbert Health Physics, Medical Physics Services, Medical Physics Services Consultants, Inc.

According to the latest research by Future Market Insights (FMI), the global market for medical physics will exceed the valuation of US$ 6 billion towards the end of projection period.

Prominently driven by the growth of medical tourism sector and increasing expanse of diagnostics, the global revenue of medical physics market will reportedly thrive at a healthy over-6% CAGR during 2018-2028. Growing adoption of nuclear medicine has also been cited as an important factor responsible for a positive growth outlook anticipated for medical physics market.

However, the report also highlights that the insufficient availability of skilled workers and relatively poor healthcare infrastructure for medical physicist trainings in developing regional markets will continue to restrict penetration of medical physics in the long run.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5274

The ‘Outsourcing’ Trend Is Creating Firm Base for Merger & Acquisition Strategies

With the consolidation of hospitals, there is an increasing need for larger firms in the medical physics market, with an intent to handle the outsourced services so as to contract with fewer services providers. The medical physics market is characterised by the presence of small independent companies, and there is a negligible number of large-scale operators. According to the report, this presents opportunities for private equity firms to enter the middle-market platform and scale-up their medium-scale operations to large-scale operations through the acquisition of smaller firms.

Other factors driving mergers and acquisitions in the medical physics market include increasing stringent regulations and an increasing number of owners looking to exit the medical physics business. Increasing stringent regulations have resulted in the inspection of a larger number of machines and associated elements. Several healthcare systems are incurring higher risks due to the increasingly stringent regulations. This opens opportunities for medical physics companies to ensure compliance and reduce operation cost by outsourcing. Furthermore, most of the medical physics firms are owned and operated by baby boomers who are about to retire from their medical physics business. For a majority of those medical physics service providers who are retiring, selling their business has been considered to be the most preferred option.

Some of the other trends in the medical physics market include increased outsourcing by healthcare providers, increasing number of independent diagnostic imaging centres, and advancements & adoption of technology across the world.
Segmental Insights: Medical Physics Market

Diagnostic modality, driven by increasing adoption of diagnostic procedures such as PET, SPECT, CT, and MRI, will continue to account for more than 65% share of the total medical physics market value.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-5274

Based on services, accreditation assistance is slated to remain dominant, followed by safety surveys. The report anticipates physics testing and regulatory and auditing services to emerge highly potential.

Following hospitals, diagnostic imaging centers are likely to register significant adoption rate in the medical physics market through 2027.

The North American and European medical physics market will reportedly account for a majority of market value, according to FMI’s analysis on medical physics market. The report has attributed this dominance to rapid consolidation of healthcare facilities in these regions.

Some of the key players in the medical physics market include Krueger-Gilbert Health Physics, Inc., LANDAUER, Medical Physics Services, Medical Physics Services Consultants, Inc., Alyzen Medical Physics Services, Radiation Safety & Control Services, Inc., Upstate Medical Physics Services, Dade Moeller & Associates, Versant Medical Physics Services & Radiation Safety, Alliance Medical Physics Services LLC, West Physics Consulting, LLC, Associates in Medical Physics Services, Radiation Services, Inc., Jaeger Corporation, and Petrone Associates, LLC.

Global Medical Physics Market: Segmentation
Analysis by Modality

Diagnostic
Radiographic X-Ray Systems
Fluoroscopic X-Ray Systems
Dental X-Ray Systems
Mammography Systems
Computed Tomography
Magnetic Resonance Imaging
Ultrasound
SPECT
PET
Others
Therapeutic
LINAC
Brachytherapy
Others

Analysis by Service

Accreditation Assistance
Performance Testing
Physics Testing
Radiation Dose Monitoring
Radiation Safety Training
Treatment Commissioning Services
Safety Surveys
Regulatory and Auditing Services
Others

Analysis by End User

Hospitals
Ambulatory Surgical Centers
Diagnostic Imaging Centers
Academic and Research Institutes

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-5274
Analysis by Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East & Africa
About FMI:

3D Cell Culture Market Key Players : Corning Incorporated, Merck KGaA, Synthecon, Inc., Becton

The 3D cell culture market revenues surpassed US$ 778 million in 2018, as per a new FMI study. The market is estimated to grow at 7.8% y-o-y in 2019; key factors responsible for the projected market growth include,

A steady rise in global research and development expenditure
Efforts to leverage the potential of 3D cell culture to replace animal model testing
Increasing demand for biosimilar products
Extensive application of stem cell research and a growing emphasis on regenerative medicine

3D Cell Culture Market

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-2843

The FMI study finds that scaffold-based 3D cell culture techniques are highly preferred over scaffold-free 3D cell culture. Owing to the significant adoption of scaffold-based 3D cell culture, the study finds that this technique garnered over 81% of the global market revenues.

Scaffold-based 3D cell culture techniques deliver researchers with additional functional operations in terms of material – natural or synthetic and different mechanical properties.

The technique uses either hydrogel-based support or polymeric hard material based support. Both types of supports find equivalent penetration in terms of application, however revenues garnered from polymeric hard material based support are higher.

According to the study, revenues of polymeric hard material based support held over half the scaffold-based 3D cell culture technique revenues in 2018 and the trend is expected to continue in the future.

“While 2D cell culture revolutionized the research efforts in stem cells, tissue engineering, and molecular biology, 3D cell culture has pushed the boundaries of traditional 2D cell culture technique with functional superiority. As the R&D efforts continue to rise in a bid to investigate the cause of different diseases and improve human health, 3D cell culture is set to remain a highly sought-after technique in the coming years,” says FMI.

Leading Manufacturers in the 3D Cell Culture Market:

Thermo Fisher Scientific Inc.,
Merck KGaA,
Becton,
Dickinson and Company, and Lonza,
Corning Incorporated,
Synthecon, Inc.

Competitive Landscape of the Global 3D Cell Culture Market

The competition section of the 3D cell culture market represents the profiles of the key players operating in the 3D cell culture market based on the products they offer and the total revenue of the companies. Some of the key players featured in this report include Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Lonza, and Corning Incorporated.

The key manufacturers of 3D cell culture offer a wide range of products. Thermo Fisher Scientific, Inc. has developed a joint platform for advancing research in precision medicine.

Corning, one of the major leaders in 3D cell culture market, manufactures cell culture products, which include consumables (such as plastic vessels, specialty surfaces, cell culture media, and serum), as well as general labware and equipment, which are used for advanced cell culture research.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2843

Application of 3D Cell Culture in Cancer Research Prominent

The FMI study estimates that 3D cell culture application in cancer research accounted for over 31% of the 3D cell culture market revenues in 2018. Cell culture is an integral part of cancer drug discovery practices. Greater strides are underway in the field to precisely characterize the diseases and develop advanced tumor cell lines using 3D cell culture techniques.

2D culture lines are considered as a standard for in vitro pre-clinical cancer treatment screening. However, more recently, the field is turning to 3D cell culture techniques to implement an ideal experimental model that mimics the human body environment to its best.

Stem cell technology is another lucrative field for 3D cell culture market. According to the FMI study, application in stem cell technology accounted for over one-fourth of the 3D cell culture market revenues in 2018. While 2D cell culture posed challenges of scalability in stem cell technology, apart from a few challenges, 3D cell culture has provided greater density and multi-fold expansion of the culture system in stem cell technology. Other fields that utilize 3D cell culture techniques are tissue regeneration, regenerative medicine, and drug discovery.

Revenues in North America Continue to Surge

North America continued to spearhead the revenues of 3D cell culture market during the historical period and the status-quo is likely to continue in the future. In 2018, North America accounted for over two-fifths of the global 3D cell culture market revenues. The study estimates that regional revenues are expected to grow at 8% in 2019 over 2018.

Funding in research and development, especially in cancer research remains higher in the United States as compared to other developed countries. Europe also presents significant funding in R&D activities. The FMI study finds that over one-fourth of the 3D cell culture market revenues were accounted for the Europe region in 2018, of which a bulk of revenues come from Western European countries such as Germany, the UK, France, Italy and Spain.

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-2843

Key Segment Based on product type

scaffold-free 3D cell culture
scaffold-based 3D cell culture

Based on application

drug discovery
tissue regeneration & regenerative medicines
cancer research
stem cell technology
others

Based on end user

biotechnology and pharmaceuticals industries
hospital laboratories
academic research and institutes
contract research organizations

About FMI:

Viscosupplementation Market to reach a valuation of US$ 2.89 Billion by 2030

According to the study, a number of broader, and industry-specific factors will drive growth in this market, which has been relatively less impacted by the sluggishness induced by COVID-19.

Global viscosuppplementation revenues are likely to reach USD 4 billion by the end of 2030, according to a new research by ESOMAR-certified firm Future Market Insights.

As per the UN, by 2050, those aged 60 and above will account for over 20% of the global population. In other words, the UN says that by 2050 around 130 Mn people will contract osteoarthritis. These numbers point towards growth in the viscosupplementation market in the forecast period.

Covid-19 Pandemic: Viscosuppplementation Market Players Consolidating their Position

The ongoing Covid-19 pandemic has compelled the market players to take a consistent path for the next two quarters. As it would take some time for the healthcare vertical to look through new product launches; the players are looking at ways to smoothen the supply chain as manpower has taken a hit.

Continuous innovations are expected to propel the growth of viscosupplementation market” says the FMI analyst

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-9509

Key Takeaways of Viscosupplementation Market Study

Three injection viscosuppplementation is expected to contribute for more than 55% of revenue share
Knee osteoarthritis is expected to gain around one-third of market share during the forecast period
North America is the highest revenue generating market due to scientific advancements and high adoption of viscosuppplementation

New Product Development to be the Torchbearer

The market players are into the innovation mode to strengthen their foothold in the viscosupplementation market. This competitive landscape is all set to create ripples all across the market. Some of the innovations are:

Fidia Pharma USA Inc., in 2019, introduced a HA (Hyaluronic Acid) based intra-articular viscosupplement called “TRILURON” to treat knee osteoarthritis. The treatments cycle involves 3 injections at weekly intervals.
Japan-based Seikagaku Corporation, in Mar 2019, launched an intra-articular single-injection viscosupplement called “HyLink” in Italy for treating knee osteoarthritis.
Recently, Gel-One Hyaluronate was approved as one of the injectable gels to treat osteoarthritis of knee. The pre-market clinical study reported no pseudosepsis (severe acute inflammatory responses).

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-9509

Want more insights?

Viscosupplementation market, a new study from Future Market Insights, opines on the viscosupplementation from 2015 – 2019 and presents demand projections from 2020 – 2030 on the basis of; product types (single injection viscosupplementation, three injection viscosupplementation, and five injection viscosupplementation), application (knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, and others such as elbow and ankle joint osteoarthritis), and end user (hospitals, ambulatory surgical centers, orthopedic clinics, retail pharmacies, and online sales) across seven prominent regions.

Viscosupplementation Market: Segmentation

The global viscosupplementation market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

Product Type

Single Injection Viscosupplementation
Three Injection Viscosupplementation
Five Injection Viscosupplementation

Application

Knee Oseteoarthritis
Hip Oseteoarthritis
Shoulder Oseteoarthritis
Others

Region

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa (MEA)

About FMI:

Direct-to-Consumer Genetic Testing Market is estimated to grow at a CAGR of 11.2% from 2022 to 2032

[300 Pages Report] As per Future Market Insights’ latest study, the global direct-to-consumer genetic testing market stood at around US$ 1.3 Bn in 2021 and is projected to exhibit a CAGR of 11.2% over the forecast period, with an estimated valuation of US$ 4.0 Bn in 2032.

The direct-to-consumer genetic testing market is expected to grow at a steady pace due to increasing demand for personalized medicines in healthcare facilities for personal use, as well as safety of patients’ health. Emergence of various epidemics and their looming health dangers is also projected to boost the demand for direct-to-consumer genetic testing solutions among the general public and healthcare professionals, thereby supporting the market.

Direct-to-Consumer Genetic Testing Market Estimated Size (2022E)	US$ 1.4 Bn
Projected Market Valuation (2032F)	US$ 4.0 Bn
Value-based CAGR (2022-2032)	11.2%
Collective Value Share: Top 5 Countries (2022E)	56.4%

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15137

Furthermore, ongoing in terms of characterization of DNA sequence variants related to the risk of commonly diagnosed diseases such as Crohn’s disease, type-2 diabetes, breast cancer, MI, and prostate cancer are set to aid growth. Despite significant attempts by dedicated researchers, only a few sequence variants associated with these diseases had been appropriately verified by replication in well-powered studies before 2006.

In addition, development of cutting-edge microarray genetic analysis technologies is expected to enable researchers to determine genotypes at hundreds and thousands of single-nucleotide polymorphisms (SNPs) instantaneously and cost-effectively across the genome. Additionally, key players are focusing on novel product developments with enhanced efficacy in terms of efficiency and safety.

For instance, in August 2020, Ancestry, a global leader in family history and consumer genomics, announced the launch of AncestryHealth. It is powered by next generation sequencing (NGS), which would help in providing easy access to important information about wellbeing to consumers.

Key Takeaways: Direct-To-Consumer Genetic Testing Market

By product, the ancestry tests segment is projected to held approximately 8% of the direct-to-consumer genetic testing market share in 2021.
Based on technology, the single nucleotide polymorphism chips segment generated a market share of around 5% in 2021.
In terms of sample, the saliva category held approximately 3% of the direct-to-consumer genetic testing market share in 2021.
The U.S. direct-to-consumer genetic testing market remained at the forefront in 2021 by generating a share of 1%.
In Asia Pacific, China direct-to-consumer genetic testing market is anticipated to exhibit steady growth at a CAGR of 5% in the forthcoming years.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15137

“Rising initiatives to promote health & well-being and introduction of microarray genetic analysis platforms are set to propel the direct-to-consumer genetic testing market across the globe,” says an analyst of Future Market Insights.

Market Competition

The direct-to-consumer genetic testing market is fragmented with the presence of various local, emerging, as well as established players across the globe. Key players are initiating promotional activities to introduce novel direct-to-consumer genetic testing kits with enhanced efficacy.

In October 2021, 23andMe, Inc. signed a merger agreement with Lemonaid Health, Inc. The acquisition would provide customers with telemedicine facilities for the assessment of their medical health and other related services online.

More Valuable Insights on Direct-To-Consumer Genetic Testing Market

Future Market Insights offers a unique perspective and actionable insights on the direct-to-consumer genetic testing market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the product (pharmacogenetics tests, carrier screening tests, genetic health risk (GHR) tests, cancer predisposition tests, low-risk general wellness tests, and ancestry tests), technology (single nucleotide polymorphism chip and whole-genome sequencing), sample (saliva, blood, and urine), sales channel (institutional sales (hospitals, specialty clinics, diagnostic laboratories, and others) and retail sales (retail pharmacies and online sales)) across seven key regions of the world.

Key Players :

23andMe
Ancestry DNA
Color Genomics, Inc.
Genetic Technology (EasyDNA)
Full Genomes Corporation, Inc.
Helix OpCo LLC
IDENTIGENE, LLC/ DNA Diagnostics Center
Living DNA Ltd
MyHeritage Ltd
Prenetics Limited
Family Tree DNA
Interleukin Genetics/orig3n
Counsyl/Myriad Genetics, Inc.
Veritas Genetics
Fulgent Genomics

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15137

Direct-to-Consumer Genetic Testing Market Outlook by Category

By Product:

Pharmacogenetics Tests
Carrier Screening Tests
Genetic Health Risk (GHR) Tests
Cancer Predisposition Tests
Low-Risk General Wellness Tests
Ancestry Tests

By Technology:

Single Nucleotide Polymorphism Chip
Whole Genome Sequencing

By Sample:

Saliva
Urine
Blood

By Sales Channel:

Institutional Sales
- Hospitals
- Specialty Clinics
- Diagnostic Laboratories
- Others
Retail Sales
- Retail Pharmacies
- Online Sales

About FMI:

Spinal Osteosynthesis Units Market is expected to grow at a steady CAGR of 4.8% From 2022 – 2032

[250 Pages Report] Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Spinal Osteosynthesis Units Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period.

Impact of COVID-19 on the Healthcare Industry

The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-9583

The team of analysts at Future Business Insights are focussing on research and market study to produce different Spinal Osteosynthesis Units Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Spinal Osteosynthesis Units Market.

Key Players

Some of the key players present in global spinal osteosynthesis units market are Medtronic, Stryker, Johnson & Johnson, Zimmer Biomet, NuVasive, B. Braun, Globus Medical, Alphatec, Orthofix, Xtant Medical, Wego, MicroPort, RTI Surgical, Integra LifeSciences, Ulrich Medical and others.

Segmentation

The global Spinal Osteosynthesis Units market is segmented by product type, surgical approach, patient type, end user, and regions:

Spinal Osteosynthesis Units Segmentation by Product Type

Thoracolumbar Osteosynthesis Unit
Lumbar Spinal Osteosynthesis Unit
Lumbosacral Osteosynthesis Unit
Thoracolumbosacral Osteosynthesis Unit
Occipitocervicothoracic Osteosynthesis Unit
Cervical Thoracic Lumbo Sacral Osteosynthesis Unit

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-9583

Spinal Osteosynthesis Units Segmentation by Surgical Approach

Posterior
Anterior
Lateral

Spinal Osteosynthesis Units Segmentation by Patient Type

Adult
Pediatric

Spinal Osteosynthesis Units Segmentation by End User

Hospital
Specialty Clinic
Others

Ask for TOC @ https://www.futuremarketinsights.com/toc/rep-gb-9583

Queries Solved

What is the size of the overall Spinal Osteosynthesis Units Market in the Healthcare Industry and its segments?

What are the key segments and sub-segments in the market?

What are the key drivers, restraints, opportunities, and challenges of the Spinal Osteosynthesis Units Market in the Healthcare Industry, and how they are expected to impact the market?

What are the attractive investment opportunities within the Spinal Osteosynthesis Units Market in the Healthcare Industry?

What is the Spinal Osteosynthesis Units Market in the Healthcare Industry size at the regional and country-level?

What are the key market players focusing on?

What are the strategies for growth adopted by the key players in Spinal Osteosynthesis Units Market in the Healthcare Industry?

What are the recent trends in Spinal Osteosynthesis Units Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)?

What are the challenges to the Spinal Osteosynthesis Units Market in the growth of the Healthcare Industry?

What are the key market trends impacting the growth of the Spinal Osteosynthesis Units Market in the Healthcare Industry?

Reasons to buy the report

We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.
Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.
The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources.

About FMI:

Steroid-Free Nasal Sprays Market is anticipated to reach US$ 14.9 Billion by 2032

[225 Pages Report] Steroid-free nasal sprays are medications that are directly delivered to nasal cavities with the avoidance of first-pass metabolism and also provide better bioavailability. It includes nasal antihistamine sprays, nasal decongestant sprays, nasal anticholinergic sprays, and nasal cromolyn sodium sprays.

As per Future Market Insights’ latest industry analysis, the global steroid-free nasal sprays market was valued at over US$ 7.75 Bn in 2021 and is expected to exhibit a CAGR of 6.3% over the forecast period, pushing the market size to US$ 14.9 Bn by 2032.

Data Points	Market Insights
Steroid-free Nasal Sprays Market Base Yea Value (2021)	US$ 7.7 Bn
Estimated Market Size (2022)	US$ 8.1 Bn
Projected Market Valuation (2032)	US$ 14.9 Bn
Value-based CAGR (2022-2032)	6.3%
Share of Top 5 Countries	57.9%

There is a subsequent rise in the prevalence of allergic rhinitis worldwide due to several risk factors including urbanization and environmental pollutants. According to a recent study conducted in 2022, allergic rhinitis affects about 25% to 40% of the population worldwide. It also states that approximately 80% of allergic rhinitis symptoms develop before the age of 20.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15127

Recently, there has been an increasing emphasis on mental illnesses due to the significant rise in cases of major depressive disorders. Among these, depression is a common mental disorder. According to WHO, approximately 280 million people of all ages suffer from depression.

Due to rising adverse effects of depression, manufacturers in the steroid-free nasal sprays market are focusing on introducing products that can be used for the treatment of these disorders in the most effective manner.

Moreover, an increased number of regulatory approvals have been observed in the steroid-free nasal sprays market which is propelling the launch of innovative products. Therefore, manufacturers in the market are focusing on getting regulatory approvals to improve sales in the market.

“Rising availability of generic nasal sprays, along with increasing promotional activities by manufacturers at online channels will boost sales of steroid-free nasal sprays over the assessment period,” says an FMI analyst.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15127

Key Takeaways:

Based on product type, sales of nasal antihistamine sprays will increase at a 5.9% CAGR through 2032.
The aqueous by formulation segment dominated the steroid-free nasal sprays market with around 4% share in 2021.
In terms of distribution channels, demand in the institutional segment will grow at a 6% CAGR through 2032.
North America accounted for the highest share of 6% of the global steroid-free nasal sprays market share in 2021.

Competition Landscape

Prominent players operating in the global steroid-free nasal sprays market are focusing on the development, launch, and approval of innovative products to improve their product portfolios. For instance:

In February 2022, Glenmark Pharmaceuticals Limited along with SaNOtize Research & Development Corp. announced the launch of FabiSpray, the nitric oxide nasal spray for the treatment of COVID-19 in India.
In March 2021, Cipla Limited announced that it has received final approval from the FDA for its abbreviated new drug application (ANDA) for Sumatriptan Nasal Spray, 20 mg which is an AB-rated generic therapeutic equivalent version of GlaxoSmithKline’s Imitrex nasal spray.

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the steroid-free nasal sprays market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032. The global steroid-free nasal sprays market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The steroid-free nasal sprays market is segmented into three parts based on the product (nasal antihistamine sprays, nasal decongestant sprays, nasal anticholinergic sprays, nasal cromolyn sodium sprays, and others), formulation (aqueous, suspension, nonaqueous-based solution, hydroalcoholic, emulsions, and dry powder/micro particles) and distribution channel- (institutional sales {hospitals, specialty clinics, community clinics, public health agencies, and others}, retail sales {retail pharmacy, drug stores, mail order pharmacy}), across seven key regions of the world.

Key Players :

Janssen Pharmaceutical, Inc.
Astra Zeneca Plc.
Cipla Ltd.
Glenmark Pharmaceuticals
Glaxosmithkline Plc.
Novartis International AG
Procter & Gamble
Sanofi S.A. (Sanofi-aventis LLC.)
Boehringer Ingelheim GmbH
AdvaCare Pharma
Bayer AG (Bayer Consumer Health
Covis Pharma S.a.r.l.
Nipro Corporation (NIPRO JMI Pharma Ltd.)
Viatris Inc. (Meda Pharmaceuticals Inc.)
Perrigo Company plc
AptarGroup, Inc.
Berry Global, Inc.
URSATEC GmbH
Gerresheimer AG
Avantor, VWR International, LLC
Spectrum Laboratory Products, Inc. (Spectrum Pharmacy Products)
SKS Bottle & Packaging, Inc.
Coster Tecnologie Speciali S.p.A

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-15127

Steroid-Free Nasal Sprays Market by Category

By Product:

Nasal Antihistamine Sprays
Nasal Decongestant Sprays
Nasal Anticholinergic Sprays
Nasal Cromolyn Sodium Sprays
Others

By Formulation:

Aqueous
Suspension
Nonaqueous-Based Solution
Hydroalcoholic
Emulsions
Dry Powder/Micro Particles

By Distribution Channel:

Institutional Sales
- Hospitals
- Specialty Clinics
- Community Clinics
- Public Health Agencies
- Others
Retail Sales
- Retail Pharmacy
- Drug Stores
- Mail Order Pharmacy

About FMI:

Phakic Intraocular Lenses (IOL) Market is estimated to reach US$ 819.5 Million by the end of 2032

[280 Pages Report] As per Future Market Insights’ latest analysis, the global phakic intraocular lenses (IOL) market reached US$ 344.4 Mn in 2021. Sales are projected to grow at a 9.5% CAGR over the forecast period, with the market valuation reaching US$ 819.5 Mn in 2032.

Patients with high ametropia or contraindications to laser refractive surgery are treated with phakic intraocular lenses (pIOLs). The key aspect that makes these lenses ideal for use in young adults seeking ocular prescription independence is the preservation of accommodation, as lens extraction is not required.

Furthermore, as the number of people who are myopic has increased in recent years, this refractive correction option has become increasingly significant. Simultaneously, it is an important area of research in light of future estimates of the prevalence of simple myopia and, more importantly, severe myopia.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15128

Because of the aesthetic and optical constraints of the conventional ophthalmic lens, as well as growing trend of contact lens overuse, phakic IOLs are a viable option for individuals with severe myopia.

Although phakic intraocular lenses have some benefits over laser refractive surgery, such as reversibility, enhanced optical quality in high ametropias, and a wider range of correction, etc., it is important to remember that it is a surgical procedure with all of the risks that are associated with intraocular surgeries, including severe complications including endophthalmitis.

Growing concerns with increasing ocular disease indication burden, high prevalence of diabetes and associated retinopathy, as well as the development of alternatives to removable spectacles and lenses for corrective vision are chief factors expected to drive the market.

“Advances in excimer laser procedures have presented a gateway into the development of implantable intraocular lenses with effective vision correction outcomes. Such developments are anticipated to auger well for the market over the forecast period,” says an FMI analyst.

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-15128

Key Takeaways:

Based on product type, the posterior chamber phakic IOL segment accounted for 0% of the total market share in 2021 and the trend is expected to continue through 2032.
By indication, sales in the astigmatism segment will increase at a 8.5% CAGR over the assessment period.
In terms of end user, the hospitals segment will remain most lucrative over the forecast period.
The U.S. is expected to lead the North America phakic intraocular lenses market over the assessment period.
Demand in China is expected to grow at a 10.5% CAGR through 2032.
Germany will emerge as a lucrative pocket, with sales rising at a 9.3% CAGR over the forecast period.

Competition Landscape

Key players are investing in research and development to offer patient-specific and indication-specific pIOLs to enhance procedural outcomes. They are also focusing on new product launch activities, licensing of product sales within a specific region, as well as regulations associated with new device development and manufacturing. For instance:

In January 2019, owing to the high regulatory standards, precision and quality requirements in Germany and Japan, Star Surgical announced expanded recommended diopter range for their EVO Visian ICL in both the countries.
In December 2019, Johnson & Johnson Vision announced the Food and Drug Administration (FDA) approval and U.S. launch of TECNIS Toric II 1-Piece Intraocular Lens (IOL).

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15128

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the phakic intraocular lenses (IOL) market in its latest study, presenting a historical demand assessment of 2017 – 2021 and projections for 2022 – 2032.

The research study is based on the product – (posterior chamber phakic IOL, and anterior chamber phakic IOL), by indication (myopia, hyperopia, and astigmatism), by end user (hospitals, ophthalmology clinics, and ambulatory surgical centres), across seven key regions of the world.

About Healthcare Division at Future Market Insights

Future Market Insights facilitates corporates, government, investors, and associated audiences in the healthcare sector to identify and accentuate vital aspects applicable to product strategy, regulatory landscape, technology evolution, and other crucial issues to achieve sustainable success. Our unique approach to gathering market intelligence equips you in devising innovation-driven trajectories for your business.

About FMI:

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

INR Test Meter Market is estimated to enjoy a valuation of US$ 1.3 Bn by the end of 2022

[300+ Pages Report] The market for INR test metres is anticipated to reach US$ 1.3 billion by the end of 2022, growing at a CAGR of 6.3 percent, and surpassing US$ 2.4 billion by 2032. With a market share of approximately 79.7% in 2021, the devices segment dominated the global INR test metre market in terms of product type.

As per Future Market Insights, the global INR test meter market was around US$ 1.2 Bn in 2021, and is projected to exhibit a CAGR growth of close to 6.3% over the forecast period, exceeding valuation of US$ 2.4 Bn in 2032.

Patients with coagulopathic aberrations related to pathological conditions have a strong reliance on PT diagnostic platforms. Patients who take warfarin frequently have medical conditions that put them at high risk for severe illness, including hospitalization, intensive care admissions, and death, as per the Centers for Disease Control and Prevention.

Get a Sample Copy of the Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-15124

With the emerging importance of utilizing point-of-care tests, the market for INT test meters is set to witness high demand during the forecast period (2022-2032). One of the primary factors driving the growth of the INR test mater market is rising prevalence of cardiovascular diseases and blood disorders across the globe.

Demand for INR test meters is expected to grow due to increased awareness of these disorders, which will improve diagnostic rates and preventive care management. Further, with favorable government funds and investments for acquiring and installing such medical devices in public healthcare facilities, the demand in the market is projected to surge through 2022 & beyond.

Key Takeaways from Market Study

In terms of product, devices held approximately 7% of market value share in 2021, owing to their efficacy in delivering positive therapeutic outcomes.
Based on end users, hospitals segment is expected to register a CAGR of 8% during the forecast period.
North America is considered as the leading region with a value share of 6% in 2021, owing to high lifestyle associated disease cases, and rapid device approvals.
The U.K. is expected to lead the growth in Europe INR test meter market backed by its development in healthcare infrastructure

Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-15124

“Growing advancements of digital solutions for medical use is set to propel the sales of the INR test meter market across the globe,” says an analyst of Future Market Insights.

Market Competition

Key manufacturers in the INR test meter market are adopting strategic approaches such as mergers and research activities for revenue growth and product portfolio expansion. Producers are also engaged in several patent expiry mitigation approaches to further provide upgraded product lines, thus establishing a strong geographical outlook.

In November 2021, CoaguSense Inc. incorporated a novel “Prothrombin Time Home Testing System” connected with MedM remote care platform.
In May 2021, Biosynex acquired Avalun to become a European leader in rapid diagnostic testing.

Buy Now/Purchase @ https://www.futuremarketinsights.com/checkout/15124

What Does the Report Cover?

Future Market Insights offers a unique perspective and actionable insights on the INR test meter market in its latest study, presenting a historical demand assessment of 2012 – 2021 and projections for 2022 – 2032.

The research study is based on the product – (device, lancet, and test strips), by end user (hospitals, speciality clinics, ambulatory surgical centres, and home care settings), across seven key regions of the world.

About Healthcare Division at Future Market Insights

About FMI:

Keloid Treatment Market is likely to record a CAGR of 8.75% through 2032

According to the latest market report published by Future Market Insights titled ‘Keloid Treatment Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027),’the global keloid treatment market is estimated to be worth US$ 3,145.8 Mn by 2017 end, and is expected to expand at a CAGR of 3.4% over the forecast period of 2017–2027 to reach a market valuation of US$ 4,414.6 Mn by the end of 2027.

Global Keloid Treatment Market: Dynamics

The global keloid treatment market growth is substantially driven by the rising prevalence of keloid scars as well as the development of multiple keloids. A growing consciousness among patients regarding their appearance is also driving the market of keloid treatment as keloid scars on the exposed body parts leads to ugly appearances. Other factors that are driving the growth in the keloid treatment market include increasing reimbursement for keloid therapies, formalisation of standard treatment guidelines for keloid and increasing use of combination therapies.

Clinics and hospitals are focussing on the adoption of advanced therapy options. CryoShape is used to reduce the impact of keloid scar and recurrence rate. Sensus Healthcare has developed an advanced superficial radiation therapy device to impart better treatment with limited adverse reactions.

Request a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1313

Global Keloid Treatment Market: Segmental Forecast

The global keloid treatment market is segmented based on treatment type, end user and region. On the basis of treatment type, the market has been segmented intoocclusive dressing, compression therapy, cryosurgery, excision, radiation therapy, laser therapy, interferon therapy, intralesional corticosteroid injection and others. Other treatment options include dermal fillers, topical creams, 5-fluorouracil, retinoic acid and imiquimod.

Intralesional corticosteroid injection treatment segment dominates the global keloid treatment market as this procedure is considered the gold standard and is being used in combination with other therapies. Intralesional corticosteroid injection is expected to be the second most lucrative segment by treatment type, with a market attractiveness index of 2.1 during the forecast period.

Based on end user, the global keloid treatment market is segmented into hospitals, dermatology clinics, ambulatory surgical centres and others. The hospitals segment is expected to remain dominant, as most of the radiation therapies and excision procedures are performed in hospitals.

Hospitals is the largest segment by end user, which is estimated to represent US$ 1,164.7 Mn, or 37.0% share of the total market in 2017 and is projected to reach a market valuation of US$ 1,643.8 Mn, or 37.2% share of the total market by the end of 2027, expanding at a CAGR of 3.5% in terms of value.

Global Keloid Treatment Market: Regional Analysis

On the basis of region, the global keloid treatment market is segmented into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan and the Middle East & Africa.

Request a TOC@ https://www.futuremarketinsights.com/toc/rep-gb-1313

North America dominated the global keloid treatment market in 2016 and is expected to continue to dominate the global market throughout the forecast period. North America is the largest region in keloid treatment market, which is estimated to represent US$ 1,105.6 Mn, or 35.1% share of the total market in 2017 and is projected to reach a market valuation of US$ 1,549.6 Mn, or 35.1% of the total market by the end of 2027, expanding at CAGR of 3.4% in terms of value. Clinics in North America are opting advanced treatment therapies that can aid in reduced risk of recurrence.

Global Keloid Treatment Market: Vendor Analysis

Leading players in the global keloid treatment market are launching new portable and mobile radiation therapy devices and are offering better treatment options to patients. Companies are targeting dermatology clinics to market their devices, where patients are provided the first line of treatment for keloid.

Some of the players operating in the global keloid treatment market who have been profiled in the report include Novartis AG, Sensus Healthcare, RXi Pharmaceuticals, Inc., Sonoma Pharmaceuticals, Inc., Perrigo Company plc, Bristol-Myers Squibb Company, Pacific World Corporation, Valeant Pharmaceuticals International, Inc., Revitol Corporation and Avita Medical Limited.

Why Future Market Insights?

Comprehensive analysis on evolving purchase pattern across different geographies
• Detailed insights of market segments and sub-segments for historical as well as forecast period
• A competitive analysis of prominent players and emerging players in the keyword market
• Detailed information about the product innovation, mergers and acquisitions lined up in upcoming years

Ground breaking research and market player-centric solutions for the upcoming decade according to the present market scenario

Ask For Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-1313

Market segmentation

The global keloid treatment market is segmented as follows:

Keloid treatment market, by treatment type
Keloid treatment market, by end user
Keloid treatment market, by region

The keloid treatment market report begins with an overview of keloid treatment and key market definitions. This section also underlines factors influencing revenue growth of the global keloid treatment market along with a detailing of the key trends, drivers, restraints, and opportunities. The next section of the report analyses the market based on treatment type and presents the forecast in terms of value for the next 10 years. Treatment types covered in the report include:

Occlusive Dressing
Compression Therapy
Cryosurgery
Excision
Radiation Therapy
Laser Therapy
Interferon Therapy
Intralesional Corticosteroid Injection
Others

The subsequent section covers the market analysis based on end user and presents the forecast in terms of value for the next 10 years. End users considered in the report include:

Hospitals
Dermatology Clinics
Ambulatory Surgical Centres
Others

About FMI:

Contact:

Unit No: 1602-006
Jumeirah Bay 2
Plot No: JLT-PH2-X2A
Jumeirah Lakes Towers
Dubai
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs